These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12493364)

  • 1. Muscarinic receptor subtypes and management of the overactive bladder.
    Chapple CR; Yamanishi T; Chess-Williams R
    Urology; 2002 Nov; 60(5 Suppl 1):82-8; discussion 88-9. PubMed ID: 12493364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which muscarinic receptor is important in the bladder?
    Yamanishi T; Chapple CR; Chess-Williams R
    World J Urol; 2001 Nov; 19(5):299-306. PubMed ID: 11760777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
    Gillberg PG; Sundquist S; Nilvebrant L
    Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolterodine--a new bladder-selective antimuscarinic agent.
    Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
    Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
    Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.
    Hashim H; Abrams P
    Drugs; 2004; 64(15):1643-56. PubMed ID: 15257626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies.
    Hegde SS; Mammen M; Jasper JR
    Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptors in the bladder: from basic research to therapeutics.
    Hegde SS
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptors: what we know.
    Scarpero HM; Dmochowski RR
    Curr Urol Rep; 2003 Dec; 4(6):421-8. PubMed ID: 14622493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle.
    Choppin A; Eglen RM
    Br J Pharmacol; 2001 Feb; 132(4):835-42. PubMed ID: 11181424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.
    Schneider T; Hein P; Michel-Reher MB; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):71-8. PubMed ID: 16059734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
    Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.
    Hegde SS; Eglen RM
    Life Sci; 1999; 64(6-7):419-28. PubMed ID: 10069505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
    Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolterodine use for symptoms of overactive bladder.
    Ruscin JM; Morgenstern NE
    Ann Pharmacother; 1999 Oct; 33(10):1073-82. PubMed ID: 10534221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional.
    Chess-Williams R
    Auton Autacoid Pharmacol; 2002 Jun; 22(3):133-45. PubMed ID: 12452898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs.
    Noronha-Blob L; Kachur JF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):562-7. PubMed ID: 1993995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.